Correlation Between Monopar Therapeutics and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on Monopar Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Terns Pharmaceuticals.
Diversification Opportunities for Monopar Therapeutics and Terns Pharmaceuticals
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Monopar and Terns is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Terns Pharmaceuticals
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 1.53 times more return on investment than Terns Pharmaceuticals. However, Monopar Therapeutics is 1.53 times more volatile than Terns Pharmaceuticals. It trades about 0.22 of its potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 1,621 in Monopar Therapeutics on August 30, 2024 and sell it today you would earn a total of 449.00 from holding Monopar Therapeutics or generate 27.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monopar Therapeutics vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Monopar Therapeutics |
| Terns Pharmaceuticals |
Monopar Therapeutics and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Terns Pharmaceuticals
The main advantage of trading using opposite Monopar Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |